Offer Erez Selected Research

Insulin Resistance

2/2010	Retinol binding protein 4: an adipokine associated with intra-amniotic infection/inflammation.
8/2009	Maternal plasma visfatin in preterm labor.
1/2009	Maternal visfatin concentration in normal pregnancy.
12/2008	Resistin in amniotic fluid and its association with intra-amniotic infection and inflammation.
1/2007	Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women.
1/2007	Resistin: a hormone which induces insulin resistance is increased in normal pregnancy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Offer Erez Research Topics

Disease

58	Pre-Eclampsia (Preeclampsia) 07/2022 - 12/2005
47	Inflammation (Inflammations) 06/2022 - 06/2007
42	Infections 06/2022 - 10/2005
29	Premature Obstetric Labor (Premature Labor) 12/2021 - 10/2005
20	Chorioamnionitis 12/2022 - 09/2007
13	Pregnancy Complications 01/2020 - 01/2007
11	Fetal Death 07/2022 - 09/2007
10	Disseminated Intravascular Coagulation 09/2022 - 08/2009
10	Rupture 06/2022 - 01/2008
10	Preterm Premature Rupture of the Membranes 05/2015 - 10/2008
9	Premature Birth (Birth, Premature) 01/2021 - 03/2006
8	Pyelonephritis 07/2022 - 10/2007
8	Thrombosis (Thrombus) 01/2022 - 08/2009
7	Hemorrhage 12/2022 - 06/2007
7	Fetal Growth Retardation (Intrauterine Growth Retardation) 07/2022 - 01/2011
7	Overweight 01/2010 - 01/2007
6	Abruptio Placentae (Placental Abruption) 09/2022 - 08/2009
6	Hemolysis 09/2022 - 10/2015
6	Birth Weight (Birth Weights) 10/2021 - 01/2003
6	Insulin Resistance 02/2010 - 01/2007
5	HELLP Syndrome 09/2022 - 04/2017
5	Stillbirth 09/2022 - 10/2015
5	Hypertension (High Blood Pressure) 05/2021 - 08/2007
4	Postpartum Hemorrhage 12/2022 - 04/2015
4	Diabetes Mellitus 05/2021 - 01/2009
4	Gestational Diabetes (Gestational Diabetes Mellitus) 05/2021 - 01/2009
4	Obesity 01/2010 - 12/2008
3	Maternal Death 12/2022 - 03/2017
3	Eclampsia 09/2022 - 10/2015
3	Neoplasms (Cancer) 01/2020 - 05/2015
3	Thrombophilia 10/2019 - 09/2007
3	Oligohydramnios 07/2019 - 08/2007
3	Sepsis (Septicemia) 01/2018 - 02/2010
3	fetal inflammatory response syndrome 07/2017 - 09/2007
3	Placenta Previa 08/2015 - 08/2012
2	Suppuration 12/2022 - 05/2018
2	Acute fatty liver of pregnancy 01/2022 - 10/2015
2	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 05/2021 - 01/2005
2	Autoimmune Diseases (Autoimmune Disease) 05/2021 - 07/2008
2	Uterine Hemorrhage (Uterine Bleeding) 05/2018 - 10/2015
2	Ischemia 01/2018 - 01/2006
2	Dystocia 12/2016 - 04/2008
2	Uterine Rupture 10/2015 - 06/2007

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2008
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2006
10	Dacarbazine (DIC)FDA LinkGeneric 09/2022 - 01/2014
10	Interleukin-6 (Interleukin 6)IBA 03/2021 - 09/2007
10	AdipokinesIBA 02/2010 - 01/2007
9	EnzymesIBA 09/2022 - 09/2008
9	CytokinesIBA 06/2022 - 10/2005
9	Thrombin FDA Link 01/2022 - 06/2008
9	InterleukinsIBA 12/2021 - 09/2008
8	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 07/2007
8	AdiponectinIBA 02/2010 - 01/2007
7	Biological ProductsIBA 01/2020 - 06/2008
7	ChemokinesIBA 10/2017 - 11/2007
7	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2017 - 10/2006
6	Messenger RNA (mRNA)IBA 11/2021 - 07/2008
6	Thromboplastin (Tissue Factor)IBA 01/2019 - 10/2008
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2007
5	Hemostatics (Antihemorrhagics)IBA 01/2022 - 10/2008
5	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2019 - 10/2008
5	EndoglinIBA 12/2017 - 01/2008
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017 - 01/2008
5	Nicotinamide PhosphoribosyltransferaseIBA 08/2010 - 01/2008
5	N 30IBA 08/2009 - 06/2007
4	Protein Isoforms (Isoforms)IBA 01/2019 - 01/2009
4	Complement System Proteins (Complement)IBA 01/2018 - 10/2008
4	plasma protein Z (protein Z)IBA 08/2009 - 06/2007
3	Particulate MatterIBA 12/2022 - 01/2020
3	CreatinineIBA 09/2022 - 01/2014
3	Antithrombin IIIIBA 01/2022 - 08/2009
3	ProteomeIBA 01/2019 - 06/2008
3	Galectins (Galectin)IBA 01/2019 - 01/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2018 - 03/2006
3	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 01/2018 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 08/2008
3	Furylfuramide (AF2)IBA 04/2010 - 01/2008
2	Cell-Free Nucleic AcidsIBA 06/2022 - 01/2018
2	AntithrombinsIBA 01/2022 - 11/2009
2	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2022
2	ProstaglandinsIBA 12/2021 - 12/2020
2	Fibronectins (Fibronectin)IBA 11/2021 - 06/2007
2	Progesterone FDA LinkGeneric 01/2021 - 01/2018
2	tissue-factor-pathway inhibitor 2 (PP5)IBA 01/2020 - 01/2019
2	AnticoagulantsIBA 10/2019 - 06/2015
2	A-factor (Streptomyces)IBA 06/2019 - 06/2008
2	InflammasomesIBA 04/2019 - 09/2008
2	Erythropoietin FDA Link 02/2019 - 12/2005
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2019 - 01/2017
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 01/2017
2	LectinsIBA 01/2019 - 05/2015
2	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2019 - 01/2017
2	LigandsIBA 02/2018 - 10/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 01/2017
2	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2017 - 01/2013

Therapy/Procedure

9	Cesarean Section (Caesarean Section) 12/2022 - 01/2003
5	Induced Labor 07/2022 - 12/2016
2	Therapeutics 10/2019 - 01/2015
2	Conservative Treatment 07/2019 - 06/2019